所属行业：食品饮料–调味发酵品Ⅱ–调味发酵品Ⅲ 闻泰科技：股东拟减持不超过1%公司股份 7月25日，闻泰科技（600745）发布公告称，股东珠海融林股权投资合伙企业（有限合伙）及其一致行 动人珠海格力电器股份有限公司计划自2025年8月15日至2025年11月12日，通过集中竞价交易方式减持 公司股份不超过1244.58万股，占公司总股本的1%。 高能环境：上半年净利润5.02亿元 同比增长20.85% 7月25日，高能环境（603588）发布2025年半年度报告，公司上半年实现营业收入67亿元，同比下降 11.20%；实现归属于上市公司股东的净利润5.02亿元，同比增长20.85%。 资料显示，高能环境成立于1992年8月，主营业务是固废危废资源化利用、环保运营服务及环保工程 等。 所属行业：环保–环境治理–固废治理 安琪酵母：拟5.06亿元收购晟通糖业55%股权 7月25日，安琪酵母（600298）发布公告称，公司拟收购呼伦贝尔晟通糖业科技有限公司（简称"晟通糖 业"）55%股权，交易金额5.06亿元。本次收购完成后，晟通糖业将成为公司的控股子公司，纳入公司 合并报表范围。 资料显示，安琪酵母成立于199 ...

2025.07. 24 7月24日晚间，沪深两市多家上市公司发布公告，以下是第一财经对一些重要公告的汇总，供投资者 参考。 【品大事】 农业银行：600亿元二级资本债券发行完毕 农业银行(601288)公告，公司2025年二级资本债券（第二期）（债券通）于7月24日发行完毕。本 期债券发行总规模600亿元，分为两个品种。其中品种一为10年期固定利率债券，发行规模400亿 元，票面利率为1.92%，在第5年末附有条件的发行人赎回权；品种二为15年期固定利率债券，发行 规模200亿元，票面利率为2.12%，在第10年末附有条件的发行人赎回权。本期债券募集的资金将补 充该行的二级资本。 南京新百：控股股东、实控人因流动性债务危机主要资产被司法冻结 南京新百(600682)发布股票交易异动公告称，公司目前生产经营正常，生产经营未发生重大调整或 变化，不存在影响公司股票交易价格异常波动的重大事项。截至目前，公司控股股东三胞集团有限公 司、实控人袁亚非因流动性债务危机，主要资产被司法冻结。 中金黄金：中国黄金集团内蒙古矿业有限公司已停产 中金黄金(600489)公告，目前中国黄金集团内蒙古矿业有限公司已停产。公司将根据现 ...

证券代码：300957 证券简称：贝泰妮 公告编号：2025-031 持股5%以上的股东天津红杉聚业股权投资合伙企业（有限合伙）保证向本 公司提供的信息内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗 漏。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 特别提示： 截至本公告披露日，天津红杉聚业股权投资合伙企业（有限合伙）（以下 简称"红杉聚业"）持有云南贝泰妮生物科技集团股份有限公司（以下简称" 公司"或"本公司"、"发行人"）股份40,698,614股，占公司股份总数的9.66% （本公告中公司股份总数421,292,882股，系按公司总股本423,600,000股剔除截 至本公告披露日公司回购专用证券账户中的股份数量计算而来，下同）。 红杉聚业计划在本公告披露之日起15个交易日后的3个月（即2025年8月15 日至2025年11月14日）内以集中竞价交易方式、大宗交易方式等法律、法规和 深圳证券交易所规则允许的方式合计减持公司股份的数量不超过公司股份总数 的2%（按公司股份总数421,292,882股计算，对应的股份数量为8,425,857股）。 公司于近日收到了红杉聚业出具 ...

专业、权威、深度，Since1990。 导语：行业竞 争正从"流量博弈"转向"技术比拼"。 以下文章来源于化妆品报 ，作者钱莹 化妆品报 . 据化妆品报不完全统计，2025上半年，国内外化妆品头部企业至少有近30起重要人事变动。 除此之外，珀莱雅和上海家化两家，副总经理的职位也处于空缺。 | रहे बाद कि बाद में बाद में बाद में बाद में बाद में बाद में बाद में बाद में बाद में बाद में बाद में बाद में बाद में बाद में बाद में कि की है कि की है कि कि की है कि कि की है | 职务 | 继任人 | 原职/曾就职经历 | | --- | --- | --- | --- | | 贝泰妮 | 副总经理 | 吴小静 | 上海威亮COO | | 珀莱雅 | 副总经理 | 暂时空缺 | | | | 首席研发创新官 | 孙培文 | PMPM母公司时垠集团 CSO (首席科研官) | | | 直席科学官 | 黄虎 | 上美股份CTO兼全球首席科学家 | | | CD ...

Investment Rating - The report maintains a "Positive" outlook on the cosmetics and medical beauty industry, highlighting innovative business models driving growth in the light medical beauty sector, particularly recommending attention to the company "Xinyang" [2][9]. Core Insights - The cosmetics and medical beauty sector has underperformed the market recently, with the Shenwan Beauty Care Index declining by 0.1% from July 11 to July 18, 2025, while the Shenwan Cosmetics Index fell by 0.9%, underperforming the Shenwan A Index by 2.3 percentage points [3][4]. - Innovative business models are driving growth in light medical beauty, contrasting with traditional medical beauty institutions facing stagnation due to high costs and weak consumer demand. Xinyang's high cost-performance ratio, chain operations, and app-based customer conversion model are seen as new growth drivers for the sector [9][10]. - The report emphasizes the importance of supply-side innovations in stimulating consumer demand and driving industry recovery, despite short-term macroeconomic challenges [9]. Summary by Sections Industry Performance - The cosmetics and medical beauty sector has shown weak performance compared to the market, with specific indices reflecting declines during the reporting period [3][4]. - The top-performing stocks in the sector included Zhongshun Jierou (+10.8%) and Juzibio (+6.1%), while the worst performers were Shangmei Shares (-11.1%) and Baiya Shares (-4.3%) [5]. Key Company Insights - Linqingxuan, a high-end domestic skincare brand, has seen revenue growth from 690 million yuan in 2022 to 1.21 billion yuan in 2024, with net profit turning from a loss of 6 million yuan to a profit of 187 million yuan [10][15]. - The company has established a strong product matrix and supply chain advantages, with production capacity reaching 40 million units annually [16][17]. - The report also highlights the growth of the "Plant Doctor" brand, which has achieved a net profit CAGR of 24% from 2022 to 2024, supported by a robust channel network and operational efficiencies [10][12]. Market Trends - The report notes a shift in the cosmetics market from quantity to quality, with a significant increase in e-commerce sales, which accounted for 47% of total cosmetics sales in 2024, up from 22% in 2016 [11]. - The domestic market is witnessing a rise in local brands, with a notable increase in market share for domestic products, reflecting changing consumer preferences and the impact of the "national tide" [11][28]. Financial Performance - The report indicates that the overall retail sales of cosmetics in China reached 229.1 billion yuan in the first half of 2025, with a year-on-year growth of 2.9%, although June saw a decline of 2.3% due to promotional timing [21][24]. - The performance of major companies like Meili Tianyuan is highlighted, with projected revenue of at least 1.45 billion yuan for the first half of 2025, representing a growth of at least 27% [24].

Group 1 - The core viewpoint of the article highlights the recognition of Beitaini Group as a leading brand in the international market, particularly through its inclusion in the "Top 100 Chinese Brands for Internationalization" list, showcasing its global influence and innovative capabilities [1][2] - The conference aimed to decode the successful path of Chinese brand internationalization, focusing on innovation, leadership, and brand value, thereby establishing a new image for Chinese brands on the global stage [1] - Beitaini Group has established research and development centers in Shanghai and Kunming, as well as advanced laboratories in Paris and Tokyo, to enhance international R&D collaboration [1] Group 2 - The company is set to launch its Southeast Asia headquarters in Bangkok in early 2024, further solidifying its global operational footprint [1] - Beitaini Group leverages its strong R&D capabilities and unique plant resources from Yunnan to market advanced skincare technologies, including sensitive skin and anti-aging products [1] - The core brand Winona has been recognized in the first batch of China's consumer brand list published by the Ministry of Industry and Information Technology, reflecting its brand value and market position [2]

Investment Rating - The report maintains a positive outlook on the cosmetics and medical beauty industry, indicating a "Buy" recommendation for several companies within the sector [2][14]. Core Insights - The cosmetics and medical beauty sector has shown weaker performance compared to the market, with the Shenwan Beauty Care Index rising by 1.5% from July 4 to July 11, 2025, which is below the market average [3][5]. - The introduction of new products in the regenerative medicine sector, particularly in the "童颜针" (youthful needle) category, is expected to enhance consumer interest and expand the market [2][8]. - The report highlights strong anticipated earnings growth for several key companies in the cosmetics sector for the second quarter of 2025, with notable increases in revenue and net profit for brands like 上美股份 (Shangmei), 丸美股份 (Marubi), and 珀莱雅 (Proya) [9][10][11]. Summary by Sections Industry Performance - The cosmetics and medical beauty sector has underperformed the market, with specific indices showing varied performance, such as the Shenwan Cosmetics Index increasing by 2.6% [3][5]. - The report notes that the demand for cosmetics is recovering, with a 4.1% year-on-year increase in retail sales for the first five months of 2025 [19][20]. Company Performance - 上美股份 (Shangmei) is expected to see a revenue increase of 16% and a net profit increase of 25% in the first half of 2025 [10]. - 丸美股份 (Marubi) anticipates a 22% revenue growth and a 28% increase in net profit for the second quarter of 2025 [10]. - 珀莱雅 (Proya) is projected to achieve a 10% revenue growth and a 15% increase in net profit for the second quarter of 2025 [10]. - 毛戈平 (Mao Geping) expects a significant revenue increase of 38% and a net profit increase of 35% in the first half of 2025 [10]. - 若羽臣 (Ruoyuchen) forecasts a remarkable 70% revenue growth and a 75% increase in net profit for the second quarter of 2025 [10]. Market Trends - The report emphasizes the ongoing trend of domestic brands gaining market share, with national brands occupying five of the top ten positions in the skincare market [32]. - The regenerative medicine sector is expanding, with new products enhancing consumer engagement and market growth potential [2][8]. Investment Recommendations - The report recommends focusing on companies with strong brand matrices and high growth potential, such as 上美股份 (Shangmei), 珀莱雅 (Proya), and 丸美股份 (Marubi) [14]. - It suggests monitoring companies that leverage e-commerce and social media platforms effectively, such as 若羽臣 (Ruoyuchen) and 毛戈平 (Mao Geping) [14].

Core Insights - The article highlights Betaini's leadership in the sustainable skincare industry in China, showcasing its strong ESG practices and recognition from authoritative rating agencies [1][3][4]. ESG Ratings and Recognition - Betaini received the highest "AAA" rating from Huazheng ESG and "AA" certification from Wind ESG, demonstrating its leading position in the consumer sector [3][4]. - In the 2025 Huazheng A-share ESG Excellence TOP 100 list, Betaini was included, reflecting its commitment to integrating ESG into its core strategy [1]. Environmental Initiatives - The new central factory, covering 80 acres and costing nearly 500 million, has an annual output value of 5 billion, utilizing low-carbon materials and solar energy [6]. - Betaini's packaging innovation includes a plan to recycle nearly 2.67 million empty bottles in 2024 and aims for 93% of new products to use FSC-certified paper by 2025 [7]. - The company has invested in carbon management, with a rooftop solar project generating approximately 875,000 kWh of electricity, reducing CO2 emissions by 1.18 million kg annually [9]. Biodiversity and Community Engagement - Betaini's public welfare fund has invested 3.13 million in biodiversity protection, including ecological restoration projects in Haba Snow Mountain [10]. - The company supports local education through initiatives like the "Betaini Hope Primary School" and scholarships for students [14]. Innovation and R&D - Betaini focuses on skin health and has been recognized as a "National Industrial Design Center" and "National Technology Innovation Demonstration Enterprise" [12]. - The company has developed 241 new products, contributing an additional 11.304 billion in industry value [13]. Governance and Compliance - Betaini has established a comprehensive ESG governance structure, ensuring sustainable development is integrated into management and operations [18]. - The company conducts regular audits and compliance checks to manage ESG-related risks effectively [19][20]. Future Goals - Betaini aims to deepen its ESG practices, enhance resource efficiency, and expand biodiversity projects while improving governance structures [26][23].

Core Insights - The article discusses recent developments in the nutrition and health industry, highlighting regulatory changes, new product approvals, and market trends that could impact investment opportunities [2][3][4][5][6]. Regulatory Developments - The State Administration for Market Regulation issued a guideline clarifying the definition of commercial advertising under the Advertising Law, addressing ongoing disputes in advertising enforcement [2]. - The National Health Commission approved D-alloheptulose and four other substances as new food raw materials, indicating a push for innovation in the nutrition sector [3]. - The market regulator released multiple responses to proposals regarding health food regulations, signaling a focus on traditional Chinese medicine formulations as a potential growth area [4]. Market Trends and Investment Opportunities - Yangtuo Technology Inc. submitted an IPO application to the Hong Kong Stock Exchange, aiming to raise funds for market expansion and supply chain optimization, reflecting growing investor interest in the nutrition and health sector [5]. - A report on 68 nutrition and health companies showed an average market value increase of 20% in the first half of the year, driven by rising consumer health awareness and demand for nutritional products [6]. Company Performance - New Hope Liuhe (002001) projected a net profit of 3.3 billion to 3.75 billion yuan for the first half of 2025, representing a year-on-year growth of 50% to 70% [12]. - Brother Technology (002562) expects a net profit of 60 million to 75 million yuan for the same period, marking an increase of 325% to 431% compared to the previous year [13]. New Product Launches - Guangji Pharmaceutical (000952) received a notice of administrative penalty for information disclosure violations, indicating regulatory scrutiny in the sector [14]. - TCM brand Tongrentang launched its first OTC glucosamine product, expanding its product line in the bone and joint health category [14].

Investment Rating - The report rates the cosmetics and medical beauty industry as "Positive" [2][3] Core Viewpoints - The cosmetics retail sales growth for January to May 2025 is 4.1%, an increase of 2 percentage points compared to the same period last year, indicating a steady recovery in demand [3] - The performance of leading brands remains strong, with double-digit growth, supported by the theme of self-care in new consumption trends, leading to a positive outlook for the first half of 2025 [3] - The 618 shopping festival saw strong performances from domestic brands, with notable rankings on platforms like Tmall and Douyin [3] Summary by Sections Cosmetics Industry Outlook - The report anticipates significant revenue and net profit growth for major companies in Q2 and H1 2025, with specific forecasts: - Up Beauty Co. is expected to see a revenue increase of 16% and a net profit increase of 25% [3] - Marubi is projected to grow revenue by 22% and net profit by 28% in Q2 2025 [3] - Proya is expected to achieve a revenue growth of 10% and net profit growth of 15% in Q2 2025 [3] Key Companies Performance - Notable companies and their expected performance include: - Mao Geping is projected to have a revenue increase of 38% and net profit increase of 35% in H1 2025 [3] - Ruibin is expected to see a revenue increase of 15% and net profit increase of 15% in Q2 2025 [3] - Huaxi Biological is expected to maintain stable performance with a 0% revenue growth and a 10% net profit increase in Q2 2025 [3] Investment Recommendations - The report recommends focusing on companies with strong brand matrices and comprehensive product layouts, such as Up Beauty Co., Marubi, and Proya, which are expected to benefit from the live e-commerce traffic [3] - It also highlights the importance of niche market players like Ruibin and Mao Geping, who are positioned to capitalize on the rise of personal care and domestic beauty trends [3] - For the medical beauty sector, the report suggests focusing on companies with high R&D barriers and strong profitability, recommending companies like Aimeike and Langzi [3] E-commerce and Other Segments - The report suggests monitoring e-commerce companies like Ruibin, which is expected to see significant growth in revenue and net profit [3] - In the maternal and infant sector, Kid King is projected to exceed market expectations with a revenue increase of 10% and a net profit increase of 70% in Q2 2025 [3]